Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Evaluation Of Use of Belimumab in Routine Care SEttings in Lupus Nephritis (LN): the OBSErve-LN Study

NCT06527872 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT06527872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06527872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Evaluation Of Use of Belimumab in Routine Care SEttings in Lupus Nephritis (LN): the OBSErve-LN Study
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Recruiting
Start date
October 4, 2024
Completion date
March 29, 2029
Enrollment
300 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

lupus nephritis